Przejdź do zawartości
Merck

Coformer screening using thermal analysis based on binary phase diagrams.

Pharmaceutical research (2014-02-14)
Hiroyuki Yamashita, Yutaka Hirakura, Masamichi Yuda, Katsuhide Terada
ABSTRAKT

The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method. Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies. Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature. The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sorbic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Benzoic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
4-Hydroxybenzoic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutamic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Benzoic acid, ReagentPlus®, 99%
Sigma-Aldrich
Stearic acid, ≥95%, FCC, FG
Sigma-Aldrich
Citric acid, ACS reagent, ≥99.5%
Sigma-Aldrich
Benzoic acid, purified by sublimation, ≥99%
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
Supelco
2,5-Dihydroxybenzoic acid, suitable for matrix substance for MALDI-MS, ≥99.5% (HPLC), Ultra pure
Supelco
Urea, 8 M (after reconstitution with 16 mL high purity water)
USP
Citric acid, United States Pharmacopeia (USP) Reference Standard
USP
Benzoic acid, United States Pharmacopeia (USP) Reference Standard
Fumaric acid, European Pharmacopoeia (EP) Reference Standard
Citric acid, anhydrous, European Pharmacopoeia (EP) Reference Standard
Stearic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Sorbic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Mettler-Toledo Calibration substance ME 51143091, Saccharin, traceable to primary standards (LGC)
Supelco
Benzoic acid, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
2-Hydroxybutyric acid sodium salt, 97%
Sigma-Aldrich
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
Sigma-Aldrich
L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Arginine, reagent grade, ≥98%
Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Sorbic acid, 99.0-101.0% anhydrous basis
Sigma-Aldrich
Citric acid, 99%
Sigma-Aldrich
Stearic acid, Grade I, ≥98.5% (capillary GC)
Sigma-Aldrich
Giemsa stain, technical grade, used as a blood stain